Literature DB >> 7522466

CD28-B7 interactions in T-cell activation.

J P Allison1.   

Abstract

Previous work has shown that optimal activation of CD4+ T cells requires co-stimulatory signals in addition to the primary signal provided by the antigen receptor. Recent work has demonstrated that CD28 is the primary co-stimulatory signal receptor for T cells, and B7 its natural ligand on antigen presenting cells. In the past year, it has become clear that the importance of CD28-mediated co-stimulatory signals extends to virtually all T-cell subsets. In addition, the existence of multiple ligands that are differentially expressed on antigen-presenting cells has been documented. The picture that is emerging is of a complex and dynamic interplay of co-stimulatory molecules on both the T cell and the antigen-presenting cell that serves to regulate activation. This offers novel approaches to the manipulation of immune responses in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522466     DOI: 10.1016/0952-7915(94)90120-1

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  57 in total

1.  Study of the interaction of the medium chain mu 2 subunit of the clathrin-associated adapter protein complex 2 with cytotoxic T-lymphocyte antigen 4 and CD28.

Authors:  E R Follows; J C McPheat; C Minshull; N C Moore; R A Pauptit; S Rowsell; C L Stacey; J J Stanway; I W Taylor; W M Abbott
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

2.  Human thymic stromal lymphopoietin enhances expression of CD80 in human CD14+ monocytes/macrophages.

Authors:  Reiji Hirano; Shunji Hasegawa; Kunio Hashimoto; Yasuhiro Haneda; Ayami Ohsaki; Takashi Ichiyama
Journal:  Inflamm Res       Date:  2011-01-28       Impact factor: 4.575

3.  Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein.

Authors:  Y Zhang; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 4.  Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation.

Authors:  Matthew F Mescher; Pujya Agarwal; Kerry A Casey; Christopher D Hammerbeck; Zhengguo Xiao; Julie M Curtsinger
Journal:  Semin Immunol       Date:  2007-03-26       Impact factor: 11.130

Review 5.  Effects of opioid tolerance and withdrawal on the immune system.

Authors:  Toby K Eisenstein; Rahil T Rahim; Pu Feng; Nita K Thingalaya; Joseph J Meissler
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-23       Impact factor: 4.147

6.  Down-regulation of Th2 responses by Brucella abortus, a strong Th1 stimulus, correlates with alterations in the B7.2-CD28 pathway.

Authors:  I Agranovich; D E Scott; D Terle; K Lee; B Golding
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 7.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

8.  Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals.

Authors:  S K Kim; D S Reed; S Olson; M J Schnell; J K Rose; P A Morton; L Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

Authors:  A A Hurwitz; T F Yu; D R Leach; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  Blocking effect of an immuno-suppressive agent, cynarin, on CD28 of T-cell receptor.

Authors:  Guo-Chung Dong; Ping-Hsien Chuang; Kai-chun Chang; Pey-shynan Jan; Pei-Ing Hwang; Huan-Bin Wu; Myunggi Yi; Huan-Xiang Zhou; Hueih Min Chen
Journal:  Pharm Res       Date:  2008-11-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.